CClinicalTrials.gg
RecruitingNCT05477901Updated Apr 23, 2026

Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)

An interventional study of Supplemental cash transfer in Inflammation, HPA and CBCL, sponsored by New York State Psychiatric Institute. Recruiting at 2 sites in 2 countries. Open to participants aged 23 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by New York State Psychiatric Institute · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started May 2025; still recruiting 1 year 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Randomized
Ages
23 Years to 45 Years
Sex
All
01

Study summary

This study examines the impact of Auxilio Brasil (AB), a cash transfer program to mothers of school-age children, on resource-deprived populations in Brazil and its protective effects on child neurodevelopment and mental health. The investigators will conduct a randomized clinical trial (RCT) among those already receiving AB in which 300 families will be randomized in a 1:1 ratio to receive either a high ($40/month) or low ($2/month) supplemental transfer for 2 years. Three hundred children (index child participants; 7-10 years old) will be enrolled across both study arms. Additionally, up to 150 siblings ("sibling participants;" 7-10 years old) will be enrolled. Eligible families who decide to participate will sign a study-specific informed consent (mother) and assent (child) form. The UNIFESP team will conduct the respective assessments at baseline, approximately 8- and 16- months, 24-months and approximately 6-months post-RCT.

Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment.

Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol.

Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model; and (ii) whether cash transfer-related effects persist 6 months post-RCT.

Read the detailed description

Numerous studies link childhood poverty with altered neurodevelopment with the most robust effects often in brain substrates related to executive functions (EF). Poverty is associated with reduced grey matter thickness and surface area of the prefrontal cortex (PFC), a key structure underlying EF (4,5) Poverty is also associated with altered structure and function of the hippocampus - a region essential for memory and cognitive control (5,6). Effects of poverty on brain development are thought to give rise to the well described associations between poverty, impairments in EF, and risk for mental illness (18). The possibility of lifting children out of poverty and thereby tempering poverty's malignant neurodevelopmental effects remains largely untested, particularly with brain and behavioral measures and within LMICs where poverty is widespread. To address this gap, the investigators propose a randomized clinical trial (RCT) to be conducted in low-income families in Sao Paulo, Brazil that will examine causal effects of a cash transfer program on neurodevelopment in youth. Our study builds off an existing cash transfer program (CTP) - Auxilio Brasil (AB) - and augments the cash transfer amount to a level sufficient to lift a family out of extreme poverty and poverty. Our RCT design will allow for novel causal inferences linking cash transfers to brain/behavior outcomes, while testing mechanistic hypotheses. Because the investigators are building off AB, a well-established program with a successful, national infrastructure for transferring cash, our findings could rapidly move toward implementation. Our study will inform critical unanswered questions about pasting, and CTPs generally, that could support their broader and more targeted implementation - First, if augmenting AB removes a family from poverty, does this protect child neurodevelopment? And second, if this augmented AB program protects neurodevelopment, what are the mechanisms that explain this? Providing this mechanistic framework is a key step toward refining AB and other CTPs, facilitating for example, studies aimed at targeting populations most likely to benefit, optimizing the dose/amount of the transfers, and determining the ideal timing/duration of CTPs.

Aims and Hypotheses

Aim 1: Determine the impact of high vs low cash transfers on children's exposure to adversities (ACEs) and neurodevelopment. Eligible families will be those already enrolled in Brazil's national AB program. Relative to low cash transfers, children of mothers who received high cash transfers will have:

Hypothesis 1A (H1A) - [ACEs] fewer new onset ACEs over the 24-month course of the RCT; H1B - [Neurodevelopment] greater pre-vs-post RCT increases in prefrontal activation during an EF fMRI task (Simon task),10 increased connectivity within EF-related PFC/mesolimbic circuits (resting fMRI and diffusion MRI), and improvements in EF behaviors.

Aim 2: Determine the impact of cash transfers on children's inflammatory markers and HPA activity/cortisol.

Hypothesis 2A (H2A) - Relative to low cash transfers, children of mothers who received high cash transfers will have lower pre vs-post RCT levels of pro-inflammatory markers (e.g., CRP, Il-6, TNF-a; from blood draws) and hair cortisol (HPA activity over past 2-3 months).

Hypothesis 2B (H2B) - Inflammatory and HPA activity levels (H2A) will be lower in children with fewer new onset ACEs (i.e., new ACEs occurring during the 24-month RCT). H2C [Mediation] - The effects of high cash transfers on neurodevelopment (H1B) will be mediated by the impact of cash transfers on reducing new onset ACEs (H1A) and lower inflammation and HPA activity (H2A \& H2B), while taking into account covariates and three additional pathways (see A.9 And C.6.3).

Exploratory Aim: The investigators will explore (i) whether sex/gender of the children moderates the pathways in the above mediation model (H2C); and (ii) whether cash transfer-related effects - reducing new onset ACEs and symptoms (CBCL), and improved EF behavior - persist 6 months post-RCT.

Impact: Designed to decrease inequalities, AB is one of the largest social interventions in the world, yet its impact on child mental health is unknown. Our strategy, rather than relying on prohibitively expensive multi-site designs, proposes to generate evidence about the impact of AB on child neurodevelopmental outcomes by focusing on specific, well-supported mechanisms that may underlie mental illness risk. Our findings will have strong implications for tailoring the impact of cash transfer policies to maximize child mental health gains.

02

Conditions studied

  • Inflammation
  • HPA
  • CBCL
  • Family Relations

Browse trials for

03

In context

Inflammation

3,439 studies on the registry are indexed under Inflammation; 629 are open to participants now.

This study's planned enrollment of 450 is above the median of 50 across 2,436 interventional studies indexed under Inflammation.

Browse Inflammation studies →

Lead sponsor

New York State Psychiatric Institute is the lead sponsor of 425 studies on the registry; 26 are open to participants now.

Of its 50 completed or terminated interventional studies of FDA-regulated products, 45 (90%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
23 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Mother:

Inclusion Criteria:

  1. Age 23-45 years old
  2. Receiving AB cash transfers
  3. Has at least two or more children ages 7- 10 years old at time of recruitment (up to 4 children per family)
  4. Able to consent

Exclusion Criteria:

1. Mother and child do not reside in same household

Child:

Inclusion Criterion

  1. Age 7-10 years old
  2. Intellectual Disability

Exclusion Criterion

  1. Does not reside in same household as the mother
  2. Major Axis I disorder (e.g., Autism, Schizophrenia, Bipolar)
  3. Severe Disability
  4. MRI contradictions (index child only)
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
450 participants (estimated)

Study arms

  • Experimental
    Intervention

    High supplemental transfer: $40 a month

    Other: Supplemental cash transfer

  • No intervention
    Control

    Low supplemental transfer: $2 a month

Interventions

  • OtherSupplemental cash transfer

    Supplemental cash transfer ($40/month)

06

What researchers measure

Primary outcomes

  1. Adverse Childhood Experiences (ACEs) - FHE

    Family History Epidemiologic screener is a 9-item (+subitems) checklist to asses child's ACEs, more checked items mean more ACEs.

    Time frame: Baseline

  2. Changes in Adverse Childhood Experiences (ACEs) - FHE

    Family History Epidemiologic screener is a 9-item (+subitems) checklist to asses child's ACEs, more checked items mean more ACEs.

    Time frame: 8 months

  3. Changes in Adverse Childhood Experiences (ACEs) - FHE

    Family History Epidemiologic screener is a 9-item (+subitems) checklist to asses child's ACEs, more checked items mean more ACEs.

    Time frame: 16 months

  4. Changes in Adverse Childhood Experiences (ACEs) - FHE

    Family History Epidemiologic screener is a 9-item (+subitems) checklist to asses child's ACEs, more checked items mean more ACEs.

    Time frame: 24 months

  5. Changes in Adverse Childhood Experiences (ACEs) - FHE

    Family History Epidemiologic screener is a 9-item (+subitems) checklist to asses child's ACEs, more checked items mean more ACEs.

    Time frame: 6 months post-RCT

  6. Adverse Childhood Experiences (ACEs) - CTC

    Brazilian version of the Parent-Child Conflict Tactics Scale: 22-item checklist with following subscales: non-violent discipline (NVD), psychological aggression (PSY), corporal punishment (CP), and physical maltreatment (PM). More checks in each subscales means behavior is performed more often.

    Time frame: Baseline

  7. Changes in Adverse Childhood Experiences (ACEs) - CTC

    Brazilian version of the Parent-Child Conflict Tactics Scale: 22-item checklist with following subscales: non-violent discipline (NVD), psychological aggression (PSY), corporal punishment (CP), and physical maltreatment (PM). More checks in each subscales means behavior is performed more often.

    Time frame: 8 months

  8. Changes in Adverse Childhood Experiences (ACEs) - CTC

    Brazilian version of the Parent-Child Conflict Tactics Scale: 22-item checklist with following subscales: non-violent discipline (NVD), psychological aggression (PSY), corporal punishment (CP), and physical maltreatment (PM). More checks in each subscales means behavior is performed more often.

    Time frame: 16 months

  9. Changes in Adverse Childhood Experiences (ACEs) - CTC

    Brazilian version of the Parent-Child Conflict Tactics Scale: 22-item checklist with following subscales: non-violent discipline (NVD), psychological aggression (PSY), corporal punishment (CP), and physical maltreatment (PM). More checks in each subscales means behavior is performed more often.

    Time frame: 24 months

  10. Changes in Adverse Childhood Experiences (ACEs) - CTC

    Brazilian version of the Parent-Child Conflict Tactics Scale: 22-item checklist with following subscales: non-violent discipline (NVD), psychological aggression (PSY), corporal punishment (CP), and physical maltreatment (PM). More checks in each subscales means behavior is performed more often.

    Time frame: 6 months-post RCT

  11. Child internalizing and externalizing symptoms

    Maternal report of The Child Behavior Checklist, internalizing (score ranges from 0 to 33) and externalizing (score ranges from 0 to 35) scales. More checks in each scale means more internalizing or externalizing symptoms.

    Time frame: Baseline

  12. Changes in Child internalizing and externalizing symptoms

    Maternal report of The Child Behavior Checklist, internalizing (score ranges from 0 to 33) and externalizing (score ranges from 0 to 35) scales. More checks in each scale mean more internalizing or externalizing symptoms.

    Time frame: 8 months

  13. Changes in Child internalizing and externalizing symptoms

    Maternal report of The Child Behavior Checklist, internalizing (score ranges from 0 to 33) and externalizing (score ranges from 0 to 35) scales. More checks in each scale mean more internalizing or externalizing symptoms.

    Time frame: 16 months

  14. Changes in Child internalizing and externalizing symptoms

    Maternal report of The Child Behavior Checklist, internalizing (score ranges from 0 to 33) and externalizing (score ranges from 0 to 35) scales. More checks in each scale mean more internalizing or externalizing symptoms.

    Time frame: 24 months

  15. Changes in Child internalizing and externalizing symptoms

    Maternal report of The Child Behavior Checklist, internalizing (score ranges from 0 to 33) and externalizing (score ranges from 0 to 35) scales. More checks in each scale mean more internalizing or externalizing symptoms.

    Time frame: 6 months-post RCT

  16. Access to health care

    The assessment will be based on maternal report about each child's health care utilization history including primary care, urgent care, and hospital care. Primary care visits will be classified by purpose: vaccination, routine check-up, or sick visits. Similar procedures to the ones in place in our ongoing study will be used to obtain child medical records in the primary care unit.

    Time frame: Baseline

  17. Changes in Access to health care

    The assessment will be based on maternal report about each child's health care utilization history including primary care, urgent care, and hospital care. Primary care visits will be classified by purpose: vaccination, routine check-up, or sick visits. Similar procedures to the ones in place in our ongoing study will be used to obtain child medical records in the primary care unit.

    Time frame: 8 months

  18. Changes in Access to health care

    The assessment will be based on maternal report about each child's health care utilization history including primary care, urgent care, and hospital care. Primary care visits will be classified by purpose: vaccination, routine check-up, or sick visits. Similar procedures to the ones in place in our ongoing study will be used to obtain child medical records in the primary care unit.

    Time frame: 16 months

  19. Changes in Access to health care

    The assessment will be based on maternal report about each child's health care utilization history including primary care, urgent care, and hospital care. Primary care visits will be classified by purpose: vaccination, routine check-up, or sick visits. Similar procedures to the ones in place in our ongoing study will be used to obtain child medical records in the primary care unit.

    Time frame: 24 months

  20. Child brain MRI scan

    Child participants will undergo an MRI scan (\~1 hour) to examine the function and connectivity of EF-related brain systems

    Time frame: Baseline

  21. Changes in Child brain MRI scan

    Child participants will undergo an MRI scan (\~1 hour) to examine the function and connectivity of EF-related brain systems

    Time frame: 24 months

  22. Child Executive Function

    Brazilian version of the Child Executive Functions Battery (CEF-B) assesses working memory, inhibition, flexibility and planning. Score ranges vary by domain. Higher scores mean higher capacity on specific domain.

    Time frame: Baseline

  23. Changes in Child Executive Function

    Brazilian version of the Child Executive Functions Battery (CEF-B) assesses working memory, inhibition, flexibility and planning. Score ranges vary by domain. Higher scores mean higher capacity on specific domain.

    Time frame: 24 months

  24. Changes in Child Executive Function

    Brazilian version of the Child Executive Functions Battery (CEF-B) assesses working memory, inhibition, flexibility and planning. Score ranges vary by domain. Higher scores mean higher capacity on specific domain.

    Time frame: 6 months-post RCT

  25. Biospecimen - Child hair sample

    Child hair samples to measure HPA activity (cortisol)

    Time frame: Baseline

  26. Biospecimen - Changes in Child hair sample

    Child hair samples to measure HPA activity(cortisol)

    Time frame: 24 months

  27. Biospecimen - Blood Draw - IL-6

    Primary immune measures will consist of IL-6 and CRP, consistent with prior research on inflammation and neurodevelopment.

    Time frame: Baseline

  28. Biospecimen - Blood Draw - Change in IL-6

    Primary immune measures will consist of IL-6 and CRP, consistent with prior research on inflammation and neurodevelopment.

    Time frame: 24 months

  29. Biospecimen - Blood Draw - CRP

    Primary immune measures will consist of IL-6 and CRP, consistent with prior research on inflammation and neurodevelopment.

    Time frame: Baseline

  30. Biospecimen - Blood Draw - Change in CRP

    Primary immune measures will consist of IL-6 and CRP, consistent with prior research on inflammation and neurodevelopment.

    Time frame: 24 months

  31. Family Adaptability and Cohesion Evaluation Scale-III (FACES-III)

    This 20-item parent-report scale assesses family cohesion and adaptability. Cohesion: scores range from 0-50, higher scores mean a more cohesive family. Adaptability: scores range from 0-50, higher scores mean a more adaptable family.

    Time frame: Baseline

  32. Change in Family Adaptability and Cohesion Evaluation Scale-III (FACES-III)

    This 20-item parent-report scale assesses family cohesion and adaptability. Cohesion: scores range from 0-50, higher scores mean a more cohesive family. Adaptability: scores range from 0-50, higher scores mean a more adaptable family.

    Time frame: 24 months

Secondary outcomes

  1. Food insecurity

    Mothers will be interviewed using the Brazilian adaptation of the Household Food insecurity. Scores range from 0-8. Higher scores mean more food insecurity.

    Time frame: Baseline, 24 months

  2. Changes in Food insecurity

    Mothers will be interviewed using the Brazilian adaptation of the Household Food insecurity. Scores range from 0-8. Higher scores mean more food insecurity.

    Time frame: 24 months

  3. Home observation/environment

    The quality of the child's home environment will be assessed with the Home Observation Measurement of the Environment (HOME) Inventory. Scores range from 0 to 55. Higher scores mean more quality and quantity of stimulation and support available to child in the home.

    Time frame: Baseline

  4. Changes in Home observation/environment

    The quality of the child's home environment will be assessed with the Home Observation Measurement of the Environment (HOME) Inventory. Scores range from 0 to 55. Higher scores mean more quality and quantity of stimulation and support available to child in the home.

    Time frame: 24 months

07

Study locations

1 of 2 sites recruiting
  • New York State Psychiatric Institute
    New York, New York 10032, United States
    Not yet recruiting
  • UNIFESP
    São Paulo, São Paulo 04023, Brazil
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05477901
Lead sponsor
New York State Psychiatric Institute
Collaborators
National Institute of Mental Health (NIMH)
Responsible party
Cristiane Duarte (Ruane Professor for the Implementation of Science for Child and Adolescent mental Health (in Psychiatry) at CUMC, New York State Psychiatric Institute) — Principal investigator
First posted
Jul 28, 2022
Start date
May 28, 2025
Primary completion
Jun 30, 2028 (estimated)
Completion
Jan 31, 2029 (estimated)
Last update
Apr 23, 2026

Study contacts

Cristiane Duarte, PhD
Contact
cristiane.duarte@nyspi.columbia.edu
646-774-5801
Cristiane Duarte, PhD
principal investigator · New York State Psychiatric Institute
Andrea Jackowsi, PhD
principal investigator · Federal University of São Paulo
Jonathan Posner, MD
principal investigator · Duke University
Tenneill Murray, MPH
study director · New York State Psychiatric Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion